Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Rallybio Corp

NASDAQ: RLYB · Life Sciences · 6 alerts · CIK 1739410

Share price
$15.43Close, Nov 16
Market cap
$83M
Shares outstanding
5.38MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Rallybio Corp filings on SEC EDGAR ↗

8:08 AM ET 10-Q
Financial Results

Rallybio Q3 2026 Results: Net Loss of $2.73M

Rallybio Corp has announced a proposed merger with Avenzo Therapeutics and continues to report significant losses as a pre-revenue clinical-stage biotechnology company. The company is heavily dependent on the development of its lead candidate, RLYB116, and expects to require substantial additional capital to fund future operations and clinical trials.

Key figure
Net loss $2.73M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.